Abstract:Objective To express in prokaryotic system and to analyze the antigenic specificity of EB virus(EBV) latent membrane protein 2(LMP2) multi-epitopes gene rich of T cell and B cell epitopes.Methods Using on-line prediction service, T cell epitopes and B cell epitopes of EB virus latent membrane protein 2 were predicted. The genes rich of CTL and th cell epitopes were selected as the candidate gene sequences, while B cell epitopes around them were taken into account. The finial selected multi-epitope gene was synthesized after being optimized according to prokaryotic codon bias and inserted into prokaryotic expression vector pET32a( + ) to get the recombinant plasmid: pET32a( + )/EBV-LMP2 multi-epitopes. After transformed into E. coli BL21 (DE3) and induced by IPTG, the target multi-epitopes gene can be expressed as Trx-His fusion protein. The expression products can be identified by SDS-PAGE and Western blot. Moreover, rabbit serum antibody to EBV membrane protein and nasopharyngeal carcinoma(NPC) patient serum were used respectively to detect the antigenic specificity of the multi-epitopes. Meanwhile, 6-8 weeks female BALB/c mice were immunized with EBV-LMP2 multi-epitope at 2 week intervals, three times in all, Trx-His protein and PBS were set as the control groups. At the second week after the last immunization, the mice were sacrificed. LDH and indirect ELISA were taken to detect the specific spleen CTL activityand specific IgG in serum, which reflected the immunogenicity of the EBV-LMP2 multi-epitope. Results Two amino acid sequences which locate at the LMP2 (aa195 -232 ) and LMP2 (aa419-436 ) were selected and connected in series to be the target gene. The recombinant plasmid containing EBV-LMP2 multi-epitope gene successfully constructed and the target protein was expressed in E. coli BL21 ( DE3 ). The relative molecular mass(Mr) of The expression products is about 27 × 103 , which matches up to the expected Mr. The antigenic specificity of the multi-epitopes protein was identified by Western blot and the multi-epitopes protein also can be detected by rabbit serum antibody to EBV membrane protein and NPC patient serum respectively. In the result of the animal experiment, EBV-LMP2 multi-epitope was able to induce the specific CTL activity in BALB/c mice. With the increasing of the effector: target ( E: T) 1: 5,1: 10, 1: 25, the CTL activity was also increased wih( 12.52% + 2.59% ), (21.80% + 1.08% ), (23.68% + 3.74% ) respectively; EBV-LMP2 multi-epitope was able to induce LMP2-specific antibody response(A490 =0.258 +0.040) as compared with Trx-His protein(A490 =0.095 +0.011) and PBS(A490 =0.068 +0.014,P＜0.05＝. Conclusion The EBV-LMP2 multi-epitopes gene was designed successfully and expressed precisely in prokaryotic expression system with good antigenicity and immunogenicity.

CONSTRUCTION OF THE EPSTEIN-BARR VIRUS BLRF2 GENE RECOMBINANT PLASMID AND ITS EXPRESSION IN EUKARYOTIC CELLS

Construction of Epstein-barr Virus BZLF1N-BLRF2 Gene by Overlap Extension PCR and Bioinformatics Analysis

[Construction and Identification of Recombinant Retroviral Vector and Stable Cell Line Expressing Latent Membrane Protein 2A of Epstein-Barr Virus].

Construction and expression of a spliced variant of Epstein-Barr virus bzlf1 and preparation of its polyclonal antibody.

[Expression, Purification and Activity Identification of ZtaN-p23 Fusion Protein in Escherichia Coli of Epstein-Barr Virus].

Prokaryotic Expression and Antigen Characteristics of EB Virus Latent Membrane Protein 2 ( EBV-LMP2) Multi-Epitopes

Lytic Replication and Inductive Production of Recombinant Epstein Barr Virus Visualized

[Construction of mammalian co-expression plasmid pIRES -LMP1-HSP90 beta and its expression in vitro].

[Construction and Immunological Responses of Recombinant Adenovirus Containing Epstein-Barr Nuclear Antigen 1 in Mice].

Analysis of Protein Expression Feature and Construction of Procaryotic Expression System for Human Papillomavirus Type 16 (HPV-16) E4 Gene

Construction and characterization of monoclonal antibodies specific for the R transactivator 185 of Epstein-Barr virus.

Subcellular Localization of Epstein–Barr Virus BLLF2 and Its Underlying Mechanisms

Expression and Purification of the DNA Binding Domain of the Epstein-Barr Virus Nuclear Antigen 1

Construction of Pcdna-Blc and Expression of BLC in Tumor Cells

[Construction of Pcdna3.1(+)/a2e Eukaryotic Expression Vector and Its Expression on K562 Cell].

Induction Of Epstein-Barr Virus Lytic Replication By Recombinant Adenoviruses Expressing The Zebra Gene With Ebv Specific Promoters

Construction of recombinant vector of HBVP22~e gene and its expression in HepG2 cells

Distribution of Epstein-Barr Virus Antigenic Sites on the Carboxyl Terminal End of Ribonucleotide Reductase Against Nasopharyngeal Carcinoma Serum Antibodies Using an Immunoabsorption Method

Construction of a Plasmid of HBV Core Antigen-EGFP Fusion Protein and Its Expression in Hep G2 Cell

Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells

Construction of prokaryotic expression vector of HPV16E6 gene and its expression]